3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
2
Palliative Care
2
stenoparib
1
poly ICLC
1
pasireotide
1
leucoselect phytosome
1
Waiting Lists
1
Topotecan
1
Temozolomide
1
Radiosurgery
1
PM 01183
1
Nivolumab
1
Immunoglobulins, Intravenous
1
Focus Groups
1
Exercise Therapy
1
Enalapril
1
Diet
1
Control Groups
1
Cognitive Behavioral Therapy
1
Celecoxib
1
Behavior Therapy
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Immunoglobulins, Intravenous
×
Thoracic
×
Clear all
NCT06064279
2024-09-19
HAITEN-ICI
VA Office of Research and Development
Phase 1/2
Withdrawn